Open original FDA record ↗Recall record
- FDA identifier
- Z-0991-2014
- Company in FDA record
- Biocardia, Inc.
- FDA classification date
- Feb 19, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Tyvek packaging may be worn, causing loss of package integrity.
Source facts
- Action
- Sales Representative called each affected hospital on February 7, 2014, to notify them of the recall. BioCardia has initiated a recall of Morph AccessPro due to a potential compromise of the sterile barrier. Use of this product may result in patient infection. Sales representatives contacted hospital sites identified in Attachment 3 by telephone. Script provided as follows: "BioCardia has initiated a recall of Morph Access Pro due to a potential compromise of the sterile barrier. Use of this product may result in patient infection. Our records indicate that we sold you. The recall is limited to these units in this lot sold to you. We would like to confirm if you still have the unit(s). If you do, we ask that you quarantine the unit(s) and our customer service department will contact you to coordinate the return of the unit(s)." For further questions please call (650) 226-0133.
- Initiated
- 2014-02-07
- Root cause
- Process control
- Terminated
- 2014-04-03
- Distribution
- US Distribution including the states of FL, MA, WY. OH, MI and KS.
- Recall number
- Z-0991-2014
- Recall status
- Terminated
- CDRH record ID
- 125554
- FDA classified
- 2014-02-19
- Recall event number
- 67492